KIROPRAKTISK KLINIK IBEN TOFT MADSEN ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  1.9% 1.7% 1.9% 1.7% 1.8%  
Credit score (0-100)  71 74 69 72 71  
Credit rating  A A A A A  
Credit limit (kDKK)  1.2 8.1 3.5 10.1 8.2  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -108 -94.1 -124 -117 -83.4  
EBITDA  -713 -692 -722 -716 -682  
EBIT  -713 -692 -722 -716 -682  
Pre-tax profit (PTP)  927.7 831.5 3,957.7 395.1 431.9  
Net earnings  734.9 672.0 3,356.2 349.1 374.3  
Pre-tax profit without non-rec. items  928 832 3,958 395 432  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  4,114 4,675 7,918 8,153 8,410  
Interest-bearing liabilities  870 900 1,001 739 461  
Balance sheet total (assets)  5,215 5,772 9,477 9,375 9,412  

Net Debt  -2,042 -2,940 -6,161 -6,481 -6,812  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -108 -94.1 -124 -117 -83.4  
Gross profit growth  1.0% 12.5% -31.4% 5.0% 29.0%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  5,215 5,772 9,477 9,375 9,412  
Balance sheet change%  12.1% 10.7% 64.2% -1.1% 0.4%  
Added value  -712.9 -691.9 -721.8 -715.7 -681.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -4.0 -5.0 -5.0 -5.0 -5.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  662.8% 735.6% 584.1% 609.6% 817.5%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  19.8% 16.2% 52.9% 5.0% 4.9%  
ROI %  21.0% 16.8% 55.6% 5.3% 5.1%  
ROE %  19.3% 15.3% 53.3% 4.3% 4.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  78.9% 81.0% 83.6% 87.0% 89.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  286.5% 424.9% 853.7% 905.5% 999.5%  
Gearing %  21.1% 19.3% 12.6% 9.1% 5.5%  
Net interest  0 0 0 0 0  
Financing costs %  6.0% 6.3% 7.6% 8.5% 4.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  3.9 4.4 5.4 6.7 8.1  
Current Ratio  3.9 4.4 5.4 6.7 8.1  
Cash and cash equivalent  2,912.4 3,840.1 7,162.6 7,219.7 7,273.4  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  3,227.3 3,779.0 6,921.7 6,954.6 7,124.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -713 -692 -722 -716 -682  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -713 -692 -722 -716 -682  
EBIT / employee  -713 -692 -722 -716 -682  
Net earnings / employee  735 672 3,356 349 374